TBA · NSE,BSE · Healthcare Service Provider
G.Surgiwear IPO is scheduled to open soon . The Mainboard IPO has a price band of TBA , with a minimum lot size of TBA . .
G.Surgiwear IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | TBA |
| IPO Close Date | TBA |
| Basis of Allotment | TBA |
| Initiation of Refunds | TBA |
| Credit of Shares to Demat | TBA |
| Listing Date | TBA |
Issue Size
₹740.00 Cr
Issue Price
[.]
Face Value
₹10/share
Market Lot
[.]
Retail Min Investment
[.]
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
₹370 Cr
Offer for Sale
₹370 Cr
Issue Type
book building
Open Date
TBA
Close Date
TBA
Allotment
TBA
Listing
TBA
No snapshot available yet.
Ghanshyam Das Agarwal, Renu Agarwal, Vinamra Agarwal, Rishu Agarwal, and Ghanshyam Das Agarwal HUF are the promoters of the Company.
Established in 1982 by Dr. G.D. Agrawal, G. Surgiwear Limited has evolved from a homegrown enterprise into one of India’s most successful indigenous medical device and surgical implant manufacturers. Headquartered in Shahjahanpur, Uttar Pradesh, the company was born out of a vision to design affordable, high-precision medical solutions that challenge the historical dominance of expensive, imported healthcare hardware.
The company's core operational strength lies in its diverse and highly specialized product portfolio. Surgiwear is recognized as a market leader in producing silicone implantable surgical devices including their signature hydrocephalus shunt systems used to relieve brain pressure alongside titanium cranial implants, bone wax, and premium sterile surgical drapes. Operating out of state-of-the-art, certified manufacturing units, the firm handles everything from meticulous product design to final packaging, serving over 40 global markets across Asia, Africa, and Latin America.
Driven by a veteran management team, the company achieved an operational revenue of ₹225 crore in Fiscal 2025 while scaling its export footprint. As G. Surgiwear Limited moves toward its mainboard public listing on the NSE and BSE, it is utilizing fresh capital to establish an advanced manufacturing plant in Pantnagar, Uttarakhand. This expansion reinforces its commitment to turning India into a self-reliant global hub for life-saving medical tech.
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Total Revenue | 151.24 | 169.13 | 224.85 |
| Profit After Tax (PAT) | 13.54 | 22.5 | 57.95 |
| EBITDA | 40.03 | 54.72 | 98.98 |
| Total Assets | 211.22 | 270.88 | 324.59 |
| Net Worth | 110.92 | 133.13 | 191.25 |
| Reserves & Surplus | 109.6 | 131.81 | 189.93 |
| Total Borrowing | 72.98 | 102.26 | 93.55 |
Revenue & Profit Trend
The allotment date for G.Surgiwear IPO will be announced after the subscription closes. You can check your allotment status using your PAN number or application number on the Bigshare Services Private Limited portal or BSE.
The G.Surgiwear IPO dates are coming soon. The subscription dates will be announced officially by the company and updated here once finalized.
The price band for G.Surgiwear IPO is yet to be announced.
As per market sources, G.Surgiwear IPO GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for G.Surgiwear IPO is being updated. Check the latest subscription figures by category (Retail, QIB, NII) for real-time updates.
The listing date for G.Surgiwear IPO is yet to be announced and will be updated once finalized.
No comments yet. Be the first to comment!